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I. Introduction and objectives
Introduction
The  combat  against  fungal  infections  has  higher  and  higher  importance  regarding  human
healthcare as well as in the agriculture. The higher incidence of fungal infections in humans during the
last  two  decades  has  multiple  reasons  such  as  the  widespread  application  of  immunosuppressive
therapies  and  diseases  with  immunodeficiency like  AIDS or  leukaemia.  The  development  of  new
antifungal  agents  is  very  challenging  because  the  extensive  usage  of  antimycotics  –  similarly  to
antibiotics – lead to resistance, and also because – unlike bacteria – fungi are eukaryotic organisms just
like mammalians, and therefore the high degree of physiological similarities restrict  the number of
potential molecular targets for a new drug. These factors together lead to an urgent need of newly
developed  antifungal  drugs  which  are  species-specific,  effective  and  non-toxic.  To  meet  these
requirements not only the traditional synthetic molecules are developed, but also biologics which have
higher molecular mass and more complex structure as compared to “traditional” drug molecules. 
A relatively recently discovered group of antifungal drug candidates are antimicrobial proteins
(or  also  called  antimicrobial  peptides,  abbreviated  as  AMPs).  AMPs  are  produced  by  almost  all
kingdom of organisms including bacteria, fungi and even mammalians. As a result of “biochemical
competition” between different microbial fungus species for the habitat,  a wide spectrum of potent
antimicrobial  peptides  have  been  evolved.  According  to  the  recent  scientific  literature4–13 AMPs
secreted by the Ascomycetes dividion of filamentous fungi at least ten different AMPs were proved to
be a protein with strong antifungal activity. While these molecules differ in their amino acid sequence,
specificity and mechanism of action, they share common features too. Antifungal proteins produced by
Ascomycetes can be characterized with 50 to 60 amino acid residue of length, high net charge and
relatively high  number  of  disulfide  bridges  which  results  in  a  very compact  and stable  molecular
structure,  while  their  structural  properties  such  as  beta-sheets  and  the  well-folded  globular  nature
reminds them proteins. Probably this beneficial combination of stability and specificity makes them
ideal antifungal drug candidates. One of the most extensively investigated member of this group is the
Penicillium antifungal  protein  (PAF)  which  was  the  subject  of  our  investigations  described in  my
dissertation.
The research of PAF begun more than two decades ago. The gene paf and the first isolation of
the protein was described by an Austrian research group in 1995.5 Since then, this group and the other
partners who joined to this research publish on the average one publication per year on this topic. The
studies cover a wide range of disciplines with the aim of characterization of the biochemical14,15,5,16,
physiological17–26,  or  structural14,27,28 properties  of  this  protein.  Our  structural  biology group  at  the
University of Debrecen joined to this  research in 2007. Within two years,  this  fruitful cooperation
resulted in a publication in which the atomic structure of PAF was published for the first time14. This
publication can be considered as direct precedents of my work. Having the 3D structure in our hands
initiated a bunch of new ideas and opened the window for new research areas such as structure-based
protein engineering and structural biology. Moreover, the advantageous attributes of PAF makes it an
outstanding protein model for basic spectroscopic research and the development of this two areas often
facilitate each other28,29.
As a BSc student I joined to this exciting research in 2008. After I have completed my BSc and
MSc diploma in the same topic, I could to start my post-gradual education holding the biotechnology
and structural biology toolkit and with clear aims, that I summarize above in three points.
1. In case of the solution structure of PAF published in 200914 the disulfide pattern was not determined
because the available structural data was insufficient for unambiguous cysteine-pair assignment. My
first aim was to reveal this uncertainty and determine the exact cysteine pairing using a molecular
biology approach,  by producing modified versions  of  PAF by cysteine-to-serine point-mutations.  I
intended to use the unambiguous disulfide bridges for more accurate modelling of the structure.
2. According to the published 15N-relaxation data14 PAF can be described as a rigid protein on the ps-ns
timescale.  Although  this  corroborate  with  the  extended  b-stranded  secondary  structure  and  the
stabilizing  three  disulfide  bridges,  the  “rigid  molecule  theory”  was  controversial  with  our  initial
findings  of  our  thermal  unfolding  experiments.  The  decrease  of  integral  values  at  high  and  low
temperatures without appearing new resonances on the spectra suggested that hidden exchange partner
exist in the system. I wanted to investigate this “mysterious” phenomenon in detail and I aimed to
explain the unusual spectral behaviour of this system.
3. In the frame of structure-function investigation studies in close cooperation with our partners, we
have produced several modified versions of PAF by point-mutations. One of these variants in which
aspartic acid was exchanged to serine in the position 19 showed surprisingly low antifungal activity
although its overall structure was unchanged according to our preliminary structure investigations. My
aim was the comparative investigation of this PAFD19S variant with the unmodified protein, regarding its
structure, dynamics and thermal unfolding. We intended to explain the significant functional difference
by finding potential differences in protein structure or dynamics.
II. Applied methods, equipments and investigated materials
The investigated materials
The protein PAF is originally produced by the filamentous fungus Penicillium chrysogenum. PAF was
firstly isolated from its strain ATCC 10002, which is the first expression system that was used for the
production of 15N-enriched form of PAF14. 
As our research proceeded, we needed an expression system which produces PAF (and its recombinant
variants) with a higher yield. Initially, the yeast Pichia pastoris was the system of our choice because it
was proved to be an organism that produce well-folded PAF14 with an acceptable yield (3-7 mg/L) and
the fermentation technology allows 15N and/or  13C supplementation of the growth media. The cys/ser
point-mutated  variants  of  PAF  were  produced  in  this  system,  namely  PAFC7S,  PAFC14S,  PAFC28S,
PAFC7S-C36S, and PAFC28S-C54S.
Later our partners developed a Penicillium-based expression system32 with even higher yield for PAF
(>10mg/L). This strain is the paf-knockout Penicillium chrysogenum (Dpaf Penicillium C3) which has
several advantages over the previously applied expression systems. PAFD19S and  15N-13C-labelled PAF
were produced in this  system according to  the protocol we have published32.  This technology was
successfully transferred to the our laboratory in Debrecen.
The chemically produced PAF and its intermediates was synthesized by our partner Györgyi Váradi
(University of Szeged, Faculty of Medicine, Department of Medical Chemistry) with native chemical
ligation in combination with oxidative folding27. The selectively  15N-labelled peptide (Arg-(15N)-Ala-
Gln-Ile) that were used as reference compounds for quantitative measurements were also synthesized
by her.
The applied methods
During  my  research  I  studied  the  structure  of  proteins  by  nuclear  magnetic  resonance  (NMR)
spectroscopy.  Nowadays,  NMR  became  an  indispensable  tool  of  the  modern  biological  research,
because it provides abundant and very precious structural information about macromolecules such as
nucleic acids and proteins. What makes NMR unique among other techniques is that structural data can
be obtained in atomic resolution and at the same time it provides information about molecular motions
on a  very wide  timescale.  A general  workflow of  structure  investigation  of  biologically  produced
proteins by NMR spectroscopy and computational methods is summarized above on figure 1.
 
Figure 1.: Main steps of structure investigation of biologically produced proteins by NMR spectroscopy.
De novo protein structure determination
In order to acquire multi-dimensional NMR spectra on PAF and its variants, we labelled PAF by two
type of isotope-labelling schemes: uniform  15N- or uniform  15N-13C-labelling. According to this two
approaches, two type resonance assignment strategies were applied as showed on figure 2.
Figure 2.: The applied strategies for protein backbone resonance assignment. (Left) typical 3D NMR experiments
of the 15N- labelled and (rigth) 15N-13C. Dashed lines indicate inter-residual-, solid lines show intra-residual correlations.
After backbone and sidechain resonance assignment, the crosspeaks of (15N- and/or  13C-resolved) 3D
NOESY spectra were assigned to the corresponding hydrogen pairs  automatically by means of the
ATNOS-CANDID protocol.  This  process  was simultaneously applied with the simulated annealing
molecular dynamics package Cyana 2.1. The robustness of the resulting structure models was tested by
systematic exclusion of H-H atom pairs during calculations. The final structure was refined based on
torsion angle restrains which were calculated from 13C backbone chemical shifts with the TALOS+35
algorithm.
Modelling of thermal unfolding
Thermal unfolding of PAF was investigated with a series of quantitative  1H-15N-HSQC experiments
recorded  at  different  temperatures  in  a  wide  temperature  range  (-20  -  +80°C).  The  temperature-
dependence of the crosspeak volumes were fitted based on the Gibbs-Helmholtz equations (and its
extended version).
Investigation of protein dynamics and exchange processes
Protein dynamics at the ps-ns timescale was investigated by the measurement of T1, T2 15N relaxation
times and heteronuclear NOEs. Relaxation data was evaluated according to the second model of Lipari-
Szabó formalism with the aid of the Bruker Dynamics Center.
The  directly  not-observable  low  populated  conformers  were  detected  by  CEST-NMR  (Chemical
Exchange Saturation Transfer)37 method and CEST data was evaluated with the Chemex method37.
The sidechain solvent accessability was determined by the CLEANEX38 method.
Equipment, experiment conditions and applied software
The majority of NMR spectra were recorded on a 500 MHz Bruker Avance II (Bruker BioSpin GmbH,
Rheinstetten, Germany) spectrometer equipped with a 5 mm three channel probehead with z-gradient,
at the University of Debrecen. For the temperature-dependent experiments the same spectrometer was
equipped  with  a  broadband  inverted  probehead  with  proton  detection.  NOESY experiments  were
repeated on a Bruker Avance II 700 MHz spectrometer with the kind help of Dr. Andrea Bodor at the
ELTE University in Budapest.
Every experiment  for  structure  determination  was measured  in  10  mM sodium-phosphate  solution
containing 40 mM NaCl at pH=6.0 and 298K in Shigemi tube. The temperature-dependent spectra were
recorded with the same solvent conditions in normal 5 mm glass tube except sub-zero experiments, for
which 1 mm glass capillaries were used.
NMR data was collected with the aid of Topspin 2.1 software. Sequence specific resonance assignment
was completed with the aid of CARA 2.8.1. In case of titration-type of experiments assignments were
transferred with the CCPN Analysis 2.2 program. For NOE peak-picking and assignment the ATNOS-
CANDID39 protocol was used in combination with Cyana 2.1. Dihedral angles were determined with
TALOS+35.  For  molecular  graphics, PyMOLTM Molecular  Graphics  System,  1.7.0.0.  was  used.
Modelling  of  thermal  unfolding  was  performed  with  in-house  written  scripts  in  the  Matlab  7.7
environment.
III. New scientific results
The most important achievements of this work is summarized above in six propositions.
1. By the analysis of 3D triple resonance NMR spectra complete 1H-15N-13C signal assignment was
achieved.
During the signal assignment of 15N-13C labelled PAF the previous resonance date was not considered.
The comparison of  the completeness  of  1H and  13C resonance assignments is  shown on  Figure 3.
Chemical shift data was validated and deposited to the „Biological Magnetic Resonance Data Bank”
(http://www.bmrb.wisc.edu/) (BMRB ID:19657). Due to the double labelling strategy, completeness of
both 1H, and 13C increased significantly, resulting more structural restrains for structure determination.
Figure 3. Completeness of 1H and 13C resonance assignment of PAF. The previously published dataset is shown with blue,
the completeness of the new assignment is shown with red.
2. It was proved that all the six cystein residues are indispensable for proper folding of PAF.
In order  to  investigate  the disulfide pattern of PAF,  cysteine deficient  versions  were designed and
expressed in recombinant Pichia pastoris expression system. The structure investigation of single- and
double- mutated protein forms showed that the lack of any cysteine residue in the amino acid sequence
leads to the loss of tertiary structure and therefore all the six cysteine residues are necessary for the
maturation process of PAF. 
Figure 4. Red: 1H NMR spectrum and ribbon representation of the folded native PAF. Blue:  1H NMR spectrum and
theoretical “structure” of the unfolded PAFC28S-C54S cysteine/serine doubly-exchange PAF.
3. It was confirmed by NMR spectroscopy that the structure of the synthetic PAF is identical with
the native one.
 
Figure 5. Left: Amide and aromatic region of the 1H NMR spectra of the synthetic (upper) and biologically produced
(lower) PAF. Right: 13C-1H correlation spectra (blue: Penicillium-produced, red: synthetic PAF).
Based on 1D 1H and natural isotopic abundance 2D 1H-13C HSQC spectra (as shown on figure 5.) the
tertiary structure of PAF synthesized by the combination of native chemical ligation and oxidative
folding27 is  identical  with  the  structure  of  the  isolated  one  (which  is  produced  by  Penicillium
chrysogenum).  The fact of this structural identity was the final proof for the previously ambiguous
disulfide  pattern.  The  order  of  cysteine  connections  was  determined  independently  by  mass
spectrometry in case of the synthetic PAF. 
As a confirmation of our partner’s observation we were able to reproduce the oxidative folding of the
reduced linear form of PAF as it was observed by a series of 1H NMR experiments (figure 6.). 
Figure 6. 1H NMR spectra of reduced linear PAF showing spontaneous folding upon oxidation. Upper spectrum: linear
PAF under Ar gase. Signals between 8.5-6-5 ppm clearly indicate typical unfolded protein resonances. Middle: spectrum of
the same sample after a week of the first measurement. Resonances of the folded PAF starting to appear at 0,5 ppm. Lower
spectrum: 9 weeks after the first measurement. The sample was stored at room temperature in an opened vial. In the
9-9,5 ppm region signals of HN Thr 37, Cys 7 and Cys 14 can be detected as well as methyl signal of valine 45 at 0,5 ppm. 
4. High resolution solution structure of PAF was determined, using new sets of experimentally
driven parameters, including NOEs, torsion angle and disulfide constraints.
In the knowledge of the unambiguous disulfide pattern and in possession of uniform 13C-15N enriched
protein sample, a more accurate 3D structure of PAF was determined as compared to the previously
published  model.  The  model  was  further  refined  by the  peptide  backbone  torsion  angle  restrains
derived from 13C backbone chemical shifts. The resulting structure does not differ significantly from
the previously determined one with respect  to  its  backbone conformation and secondary structure.
However,  during  the  newer  structure  determination,  disulfides  were  defined  explicitly  as  covalent
bonds. These restrains were in agreement with the majority of the NOE the distance restraints. This
computational approach also confirmed the ‘abcabc’ pattern (in which 7-36, 14-43, 28-54 cysteine
residues are connected). Furthermore, backbone RMSD values of the new model is 0.40±0.08 which
indicates well-determined spatial coordinates (as a comparison, the backbone RMSD of the previously
determined structure was 0.65±0.18).
Figure 7. Ribbon representation of the 3D structure of PAF. Arrows represent b-strandsm disulfide bridges are shown as
yellow sticks. Above the structure graphics, the sequence is shown where the  cystein pairs are connected with lines.
5. It was shown in the solution structure of PAF that several “hidden” conformers exist which are
not directly observable by NMR, and the proportion of the detectable and not directly detectable
forms can be shifted by temperature changes. 
It was shown by our thermal protein unfolding experiments that the solution structure of PAF
contains a significant amount of conformer which is not directly observable by conventional NMR
methods and the proportion of the „visible” and „invisible” fractions could be shifted by varying the
temperature. We have estimated the concentration of the unfolded fraction(s) by temperature-dependent
quantitative 2D NMR and by modeling of the temperature-induced reversible protein unfolding. The
modelling  revealed  that  the  local  thermodynamic  parameters  of  the  unfolding  depend  from  the
secondary  structure  elements:  while  reversible  thermal  unfolding  of  the  motile  terminal  and  loop
regions  could  be fitted  by two-state  model,  in  case  of  residues  which  are  positioned within  beta-
stranded elements (at least) a third conformational state had to be supposed beyond the folded and
unfolded states (and this is called the “three state model”). According to our results, the population of
the minor „invisible” conformers are not negligible. According to our estimation based on minimized
global  fit  errors,  the ratio  of the invisible  fraction was around 20-30% even at  room temperature.
Sensitive  15N-CEST–NMR  experiments  revealed  further  minor  conformations  with  even  lower
population (<1%). According to our results, these conformations are in slow exchange with the major
form and in case of some residues has significantly different chemical shift  which indicates major
structural change at these sites.
  
Figure 8. Left: Integral volumes of 1H-15N-HSQC crosspeaks in the function of temperature. Right: population of the
different fractions in function of temperature and fitting of visible and hidden conformational states based on the three-state
thermal unfolding model in case of the representative cysteine 14. Folded fraction: □, intermediate state:*, unfolded state:
◊, the two hidden state together: ○.
6. The detailed structure comparison of PAF and its inactive variant PAFD19S showed that reduced
biological  activity  of  PAFD19S can  be  explained  by  significant  changes  in  the  surface  charge
distribution and/or changes in thermal unfolding process.
The possible biological function of the “hidden” exchange partner was investigated with the aid of a
point-mutated inactive version of PAF (PAFD19S). According to antifungal activity assays, exchange of
one  critical  negatively  charged  aspartate  to  serine  by  point  mutation  at  the  position  19  almost
completely eliminated the antifungal activity of the protein. We have investigated the three dimensional
solution  structure,  ps-ns  dynamics,  amide  HN-H2O  exchange  (by  CLEANEX),  “CEST-detectable”
conformers and thermal unfolding of PAFD19S at identical conditions as our previous experiments with
PAF. While backbone chemical shifts, NOE-derived structural ensembles at the level of the overall
protein fold and 15N-relaxiation parameters showed highly similar properties between the two protein
forms, the local parameters of thermal unfolding and distribution of protein surface charge changed
significantly in PAFD19S as compared to PAF, due to reshuffling of charged side-chains. The dramatic
change of surface charges which relayed further from the site of mutation is able to prevent PAF from
binding to its primary target which gives an acceptable explanation to the loss of antifungal activity.
However, one can not exclude the possibility that the altered surface charge is not the only factor in the
inactivation of  PAF by this  single  residue  exchange.  According to  thermal  unfolding experiments,
PAFD19S proved to be a two-state folder while the thermal unfolding of PAF is closer to the three-state
unfolding model. Therefore it can not be excluded that intermediate “invisible” conformations which
are present in PAF but not (or in a less extent) in PAFD19S contribute to the antifungal mechanism.
Figure 9.  Upper part: 20 conformer ensemble of PAF (left) and PAFD19S (right) backbones. Aspartic acid 19. is highlighted
with red. Lower part surface charge of a representative conformer of PAF (left) and PAFD19S (right) calculated in vacuum.
Red: negative charge, white: neutral, blue: positive charge.
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